Visible Genomics introduces AMDiGuard, a revolutionary genetic test for hereditary age-related macular degeneration (AMD) that offers a comprehensive risk assessment, empowering both patients and physicians to make informed clinical and lifestyle decisions. By providing advanced awareness of disease risk, AMDiGuard helps in slowing or preventing the progression of AMD through personalized preventative medicine. The test is designed to be affordable, easy to use, and understandable, ensuring greater access for more patients. To begin utilizing the AMDiGuard genetic macular degeneration tests and take proactive steps towards eye health, click here to learn more.To know more watch video.
